arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Oruka Therapeutics, Inc.

ORKA
$89.93 ▼ -4.65 (-4.92%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
88 Visible periods
22 Metrics
Peer-ranked Benchmarks
Price Chart
35
Health
Weak
Neutral
auto_awesome

Analytical Summary

Oruka Therapeutics, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap
Dividend Yield
Revenue Growth
Op. Margin
ROIC -3.6%
FCF / Share None
Trailing P/E
Price / Book 4.9x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

88-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$0.00
Net Income Profit after all expenses
$-31.82M
↓ -29.5%
FCF / Share Free cash flow per share
$-0.50
↓ -375.5%

Health Breakdown

Returns
27
Cash Quality
57

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 23 years · 88 quarters